Report Detail
Global (United States, European Union and China) Amantadine HCl Oral Market Research Report 2019-2025
- RnM3696141 |
- 26 August, 2019 |
- Global |
- 123 Pages |
- QYResearch |
- Pharma & Healthcare
Amantadine is a medication that has U.S. Food and Drug Administration approval for use both as an antiviral and an antiparkinsonian medication.
In 2019, the market size of Amantadine HCl Oral is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Amantadine HCl Oral.
This report studies the global market size of Amantadine HCl Oral, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Amantadine HCl Oral sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Zydus Pharmaceuticals
Mylan
Teva
Vertical Pharmaceuticals
Adamas Pharmaceuticals
Upsher-Smith
Sandoz
Mikart Pharmaceuticals
Pharmaceutical Associates, Inc. (PAI)
Wockhardt Bio AG
CMP Pharma
Bionpharma
Graviti Pharma
Alembic Pharmaceuticals
Strides Pharma
Heritage Pharmaceuticals
Market Segment by Product Type
Tablet
Capsules
Syrup
Market Segment by Application
Parkinson's disease
Influenza
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Amantadine HCl Oral status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Amantadine HCl Oral manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Amantadine HCl Oral are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Amantadine HCl Oral Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Tablet
- 1.3.3 Capsules
- 1.3.4 Syrup
- 1.4 Market Segment by Application
- 1.4.1 Global Amantadine HCl Oral Market Share by Application (2019-2025)
- 1.4.2 Parkinson's disease
- 1.4.3 Influenza
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Amantadine HCl Oral Market Size
- 2.1.1 Global Amantadine HCl Oral Revenue 2014-2025
- 2.1.2 Global Amantadine HCl Oral Sales 2014-2025
- 2.2 Amantadine HCl Oral Growth Rate by Regions
- 2.2.1 Global Amantadine HCl Oral Sales by Regions 2014-2019
- 2.2.2 Global Amantadine HCl Oral Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Amantadine HCl Oral Sales by Manufacturers
- 3.1.1 Amantadine HCl Oral Sales by Manufacturers 2014-2019
- 3.1.2 Amantadine HCl Oral Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Amantadine HCl Oral Revenue by Manufacturers (2014-2019)
- 3.2.2 Amantadine HCl Oral Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Amantadine HCl Oral Market Concentration Ratio (CR5 and HHI)
- 3.3 Amantadine HCl Oral Price by Manufacturers
- 3.4 Key Manufacturers Amantadine HCl Oral Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Amantadine HCl Oral Market
- 3.6 Key Manufacturers Amantadine HCl Oral Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Tablet Sales and Revenue (2014-2019)
- 4.1.2 Capsules Sales and Revenue (2014-2019)
- 4.1.3 Syrup Sales and Revenue (2014-2019)
- 4.2 Global Amantadine HCl Oral Sales Market Share by Type
- 4.3 Global Amantadine HCl Oral Revenue Market Share by Type
- 4.4 Amantadine HCl Oral Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Amantadine HCl Oral Sales by Application
6 United States
- 6.1 United States Amantadine HCl Oral Breakdown Data by Company
- 6.2 United States Amantadine HCl Oral Breakdown Data by Type
- 6.3 United States Amantadine HCl Oral Breakdown Data by Application
7 European Union
- 7.1 European Union Amantadine HCl Oral Breakdown Data by Company
- 7.2 European Union Amantadine HCl Oral Breakdown Data by Type
- 7.3 European Union Amantadine HCl Oral Breakdown Data by Application
8 China
- 8.1 China Amantadine HCl Oral Breakdown Data by Company
- 8.2 China Amantadine HCl Oral Breakdown Data by Type
- 8.3 China Amantadine HCl Oral Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Amantadine HCl Oral Breakdown Data by Company
- 9.2 Rest of World Amantadine HCl Oral Breakdown Data by Type
- 9.3 Rest of World Amantadine HCl Oral Breakdown Data by Application
- 9.4 Rest of World Amantadine HCl Oral Breakdown Data by Countries
- 9.4.1 Rest of World Amantadine HCl Oral Sales by Countries
- 9.4.2 Rest of World Amantadine HCl Oral Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Zydus Pharmaceuticals
- 10.1.1 Zydus Pharmaceuticals Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Amantadine HCl Oral
- 10.1.4 Amantadine HCl Oral Product Introduction
- 10.1.5 Zydus Pharmaceuticals Recent Development
- 10.2 Mylan
- 10.2.1 Mylan Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Amantadine HCl Oral
- 10.2.4 Amantadine HCl Oral Product Introduction
- 10.2.5 Mylan Recent Development
- 10.3 Teva
- 10.3.1 Teva Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Amantadine HCl Oral
- 10.3.4 Amantadine HCl Oral Product Introduction
- 10.3.5 Teva Recent Development
- 10.4 Vertical Pharmaceuticals
- 10.4.1 Vertical Pharmaceuticals Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Amantadine HCl Oral
- 10.4.4 Amantadine HCl Oral Product Introduction
- 10.4.5 Vertical Pharmaceuticals Recent Development
- 10.5 Adamas Pharmaceuticals
- 10.5.1 Adamas Pharmaceuticals Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Amantadine HCl Oral
- 10.5.4 Amantadine HCl Oral Product Introduction
- 10.5.5 Adamas Pharmaceuticals Recent Development
- 10.6 Upsher-Smith
- 10.6.1 Upsher-Smith Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Amantadine HCl Oral
- 10.6.4 Amantadine HCl Oral Product Introduction
- 10.6.5 Upsher-Smith Recent Development
- 10.7 Sandoz
- 10.7.1 Sandoz Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Amantadine HCl Oral
- 10.7.4 Amantadine HCl Oral Product Introduction
- 10.7.5 Sandoz Recent Development
- 10.8 Mikart Pharmaceuticals
- 10.8.1 Mikart Pharmaceuticals Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Amantadine HCl Oral
- 10.8.4 Amantadine HCl Oral Product Introduction
- 10.8.5 Mikart Pharmaceuticals Recent Development
- 10.9 Pharmaceutical Associates, Inc. (PAI)
- 10.9.1 Pharmaceutical Associates, Inc. (PAI) Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Amantadine HCl Oral
- 10.9.4 Amantadine HCl Oral Product Introduction
- 10.9.5 Pharmaceutical Associates, Inc. (PAI) Recent Development
- 10.10 Wockhardt Bio AG
- 10.10.1 Wockhardt Bio AG Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Amantadine HCl Oral
- 10.10.4 Amantadine HCl Oral Product Introduction
- 10.10.5 Wockhardt Bio AG Recent Development
- 10.11 CMP Pharma
- 10.12 Bionpharma
- 10.13 Graviti Pharma
- 10.14 Alembic Pharmaceuticals
- 10.15 Strides Pharma
- 10.16 Heritage Pharmaceuticals
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Amantadine HCl Oral Sales Channels
- 11.2.2 Amantadine HCl Oral Distributors
- 11.3 Amantadine HCl Oral Customers
12 Market Forecast
- 12.1 Global Amantadine HCl Oral Sales and Revenue Forecast 2019-2025
- 12.2 Global Amantadine HCl Oral Sales Forecast by Type
- 12.3 Global Amantadine HCl Oral Sales Forecast by Application
- 12.4 Amantadine HCl Oral Forecast by Regions
- 12.4.1 Global Amantadine HCl Oral Sales Forecast by Regions 2019-2025
- 12.4.2 Global Amantadine HCl Oral Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Amantadine HCl Oral. Industry analysis & Market Report on Amantadine HCl Oral is a syndicated market report, published as Global (United States, European Union and China) Amantadine HCl Oral Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Amantadine HCl Oral market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
